Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diffuse Large B-Cell Lymphoma.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05749549
What this trial is testing

Phase I/IIa Study of BR1733 in Subjects With Advanced Cancers

Who this might be right for
Advanced CancerFollicular LymphomaPeripheral T Cell Lymphoma+1 more
Shanghai Blueray Biopharma Co., Ltd. 191
Early research (Phase 1)Study completedNCT04067414
What this trial is testing

Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaHigh-grade B-cell LymphomaTransformed Lymphoma+1 more
Institute of Hematology & Blood Diseases Hospital, China 12
Early research (Phase 1)Study completedNCT02924402
What this trial is testing

Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic Malignancies

Who this might be right for
B-cell Non-Hodgkins LymphomaChronic Lymphocytic Leukemia
Xencor, Inc. 154
Early research (Phase 1)Ended earlyNCT06254495
What this trial is testing

A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers

Who this might be right for
Hodgkin DiseaseLymphoma, T-Cell, PeripheralLymphoma, Large B-Cell, Diffuse+1 more
Seagen, a wholly owned subsidiary of Pfizer 58
Not applicableLooking for participantsNCT03375619
What this trial is testing

Long-term Follow-up Study of Patients Receiving CAR-T Cells

Who this might be right for
Chronic Lymphocytic LeukemiaLymphomas Non-Hodgkin's B-CellLymphoma, Small Lymphocytic+6 more
Medical College of Wisconsin 500
Testing effectiveness (Phase 2)UnknownNCT05290337
What this trial is testing

ZR-CHOP in DLBCL With Specific Gene Abnormality

Who this might be right for
Diffuse Large B Cell Lymphoma
Fudan University 62
Testing effectiveness (Phase 2)Looking for participantsNCT06760039
What this trial is testing

Safety and Efficacy of R-CMOP Versus R-CHOP in the Initial Treatment of DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
Sun Yat-sen University 112
Large-scale testing (Phase 3)Looking for participantsNCT04442412
What this trial is testing

Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy

Who this might be right for
Diffuse Large B-Cell LymphomaElderly Patients
Fondazione Italiana Linfomi - ETS 430
Large-scale testing (Phase 3)UnknownNCT02531841
What this trial is testing

High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma

Who this might be right for
Diffuse Large B-cell-lymphoma
University Hospital Freiburg 250
Testing effectiveness (Phase 2)Study completedNCT02077166
What this trial is testing

Ibrutinib in Combination With Lenalidomide and Rituximab in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Relapsed Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Pharmacyclics LLC. 138
Testing effectiveness (Phase 2)Ended earlyNCT00112723
What this trial is testing

Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+25 more
National Cancer Institute (NCI) 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT03277729
What this trial is testing

A Phase I/II Study to Evaluate the Safety of Cellular Immunotherapy Using Autologous T Cells Engineered to Express a CD20-Specific Chimeric Antigen Receptor for Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell Lymphoma+20 more
Fred Hutchinson Cancer Center 53
Testing effectiveness (Phase 2)Looking for participantsNCT06687772
What this trial is testing

CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant

Who this might be right for
Diffuse Large B Cell Lymphoma
Washington University School of Medicine 36
Testing effectiveness (Phase 2)Looking for participantsNCT07519772
What this trial is testing

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Who this might be right for
Lymphoma, Non-HodgkinLymphoma, FollicularLymphoma, Large B-Cell, Diffuse
Merck Sharp & Dohme LLC 280
Testing effectiveness (Phase 2)UnknownNCT02060656
What this trial is testing

Phase II Study Comparing LR-GEM to R-GEM-P in Second-line Treatment of Diffuse Large B-cell Lymphoma (LEGEND)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Royal Marsden NHS Foundation Trust 92
Testing effectiveness (Phase 2)WithdrawnNCT01854372
What this trial is testing

Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement.

Who this might be right for
Newly Diagnosed Diffuse Large B-Cell LymphomaIntermediate (Burkitt-Like) Lymphoma
The University of Texas Health Science Center at San Antonio
Large-scale testing (Phase 3)Looking for participantsNCT05820841
What this trial is testing

Acalabrutinib in Combination With R-miniCHOP in Older Adults With Untreated Diffuse Large B-Cell Lymphoma

Who this might be right for
Large B-cell LymphomaDiffuse Large B Cell Lymphoma
Universität des Saarlandes 330
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07517705
What this trial is testing

MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Nebraska 50
Testing effectiveness (Phase 2)Study completedNCT02890602
What this trial is testing

Erythropoietin for Management of Anemia Caused by Chemotherapy

Who this might be right for
Diffuse Large B-cell Lymphoma
Kosin University Gospel Hospital 53
Large-scale testing (Phase 3)Looking for participantsNCT07011056
What this trial is testing

A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
Recurrent and Refractory Diffuse Large B-cell Lymphoma
Chengdu Zenitar Biomedical Technology Co., Ltd 390
Next Page